Erica Kimmel and Nina Manguiri Join Gilbane Building Company to Expand Business Development in Maryland

Photo of Erica Kimmel and Nina Manguiri
Published on :

Gilbane Building Company is pleased to announce the addition of Erica Kimmel and Nina Manguiri as Business Development Managers in the Baltimore, MD office. Together they bring over 39 years of strategic sales experience.  Working alongside Greg Permison, who joined Gilbane in 2018, they will support Gilbane’s business development effort for continued growth and expansion in the Maryland market.

Ezekiel Kelley Joins Workforce Genetics as Director of Operations and Workforce Development Solutions

Headshot of Ezekiel Kelley
Published on :

Workforce Genetics welcomes Ezekiel Kelley as the new Director of Operations and Workforce Development Solutions. Ezekiel will establish and implement efficient operating systems to drive growth across the whole organization – including the Recruiting and BioBuzz divisions. Additionally, he will be the head architect for building innovative new workforce solutions; including a new online community and talent marketplace that seeks to expand access to virtual workforce development and education tools, increase career mobility, and democratize access to rewarding life science careers. 

Kevin Hannigan Appointed CEO at Automated Control Concepts

Published on :

Automated Control Concepts (ACC) is proud to announce that Kevin Hannigan has been appointed CEO. Kevin’s previous leadership as President of ACC has been instrumental in helping ACC achieve our recent level of remarkable success, culminating in the investment from our new partners, Sverica Capital Management. His vision for our growth is exciting and frankly inspirational.

Context Therapeutics® Strengthens Research & Development Team

Headshots of Christopher Beck and Mark Fletcher, with Context Therapeutics logo
Published on :

Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing small molecule and immunotherapy treatments for breast and gynecological cancers, today announced the appointments of Christopher Beck as SVP of Operations and Mark Fletcher, Ph.D., as VP of R&D. Context also announced the planned retirement of its current Head of CMC, Bill Rencher, Ph.D., who will move into an advisory role with the Company.

Sarah Ellinwood, Ph.D. Joins Workforce Genetics as Managing Editor for BioBuzz Media

Headshot of Sarah Ellinwood
Published on :

Sarah Ellinwood, Ph.D. Joins Workforce Genetics as Managing Editor for BioBuzz Media Workforce Genetics welcomes molecular biologist Sarah Ellinwood, Ph.D., as its new Managing Editor. Sarah will be collaborating closely [….]

Erik Crown Joins Workforce Genetics & BioBuzz to Lead Marketing & Communications

Published on :

Workforce Genetics welcomes Erik Crown as the new Head of Marketing and Communications to be the head storyteller conveying the vision for both the Talent and BioBuzz Media divisions which offer a variety of services to life science employers across several functional areas.

Biosimilars Company, BioFactura, Announces Significant Team Growth

Published on :

In a rapidly expanding market, BioFactura is making waves in a big way in 2021. From initiation of a phase 1 study for a biosimilar treatment for people suffering from Crohn’s Disease to a recent transfer agreement with RANI Therapeutics, there’s a lot to be excited about for a company of just under 50 employees.